Taken together, these results indicate that NEAT1-regulated abnormal lipolysis contributes to HCC growth, and that this process is mediated by ATGL and its product, DAG+FFA, in vivo. The gene discussed is PNPLA2; the disease is hepatocellular carcinoma.